LifeStance Health Group, Inc.
LFST
$8.10
$0.172.14%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 21.17% | 17.43% | 16.34% | 10.56% | 10.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.17% | 17.43% | 16.34% | 10.56% | 10.83% |
| Cost of Revenue | 19.88% | 18.45% | 16.46% | 10.42% | 8.49% |
| Gross Profit | 23.81% | 15.41% | 16.08% | 10.86% | 15.90% |
| SG&A Expenses | 6.16% | 1.81% | 12.70% | 2.77% | 7.09% |
| Depreciation & Amortization | -3.18% | -8.43% | -10.31% | -24.70% | -39.04% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.01% | 12.45% | 14.14% | 6.22% | 4.71% |
| Operating Income | 1,294.64% | 959.53% | 1,710.86% | 81.02% | 110.01% |
| Income Before Tax | 1,444.22% | 271.28% | 184.95% | 73.73% | 92.91% |
| Income Tax Expenses | 353.19% | 300.40% | 507.83% | -427.90% | -700.28% |
| Earnings from Continuing Operations | 1,908.89% | 264.06% | 118.08% | 83.71% | 103.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,908.89% | 264.06% | 118.08% | 83.71% | 103.36% |
| EBIT | 1,294.64% | 959.53% | 1,710.86% | 81.02% | 110.01% |
| EBITDA | 132.34% | 92.61% | 34.61% | 261.31% | 134.75% |
| EPS Basic | 1,944.44% | 260.96% | 117.83% | 84.01% | 103.21% |
| Normalized Basic EPS | 1,470.83% | 287.79% | 189.02% | 72.73% | 93.42% |
| EPS Diluted | 1,944.44% | 246.77% | 114.00% | 83.69% | 103.00% |
| Normalized Diluted EPS | 1,445.83% | 283.21% | 187.80% | 72.73% | 93.42% |
| Average Basic Shares Outstanding | 1.04% | 1.72% | 1.74% | 1.93% | 1.84% |
| Average Diluted Shares Outstanding | 1.13% | 4.09% | 2.24% | 1.93% | 3.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |